BCL2 and colorectal cancer: Recent publications demonstrated that exogenous delivery of miR-15a and, specifically, 5-FU-miR-15a significantly reduced the expression levels of YAP1 and BCL2 in pancreatic and colorectal cancer cell lines, respectively, and led to growth inhibition [29,31].